1Ueland T, Brixen K, Mosekilde L, et al. Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study[J].J Clin Endocrino
2Fahrleitner A, Prenner G, Kniepeiss D, et al. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status[J].Wien Klin Wochenscher,2002,114(15-16):717-724.
3Toraldo G, Roggia C, Qian WP, et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells[J].Proc Natl Acad Sci USA,2003,100(1):125-130.
4Schoppet M, Preissner KT, Hofbauer LC. Rank ligand and osteoprotegerin paracrine regulators of bone metabolism and vascular function[J].Arterioscler Thromb Vasc Biol,2002,22(4):549-553.
5Fahrleitner-Pamner A, Dobnig H, Piswanger-Soelkner C, et al. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status[J].Wien klin Wochenschr,2003,115(9):291-297.
6Arko B, Prezelj K, Komel R, et al. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis[J].J Clin Endocrinol Metab,2002,87(9):4078-4079.
7Langdahl Bl, Carstens M, Stenkjaer L, et al. Polymorphism in the osteoprotegerin gene are associated with osteoporotic fractures[J].J Bone Miner Res,2002,17(7):1245-1255.
8Ohmori H, Mokita Y, Funamizu M, et al. Linkage and association analyses of OPG gene locus with human osteoporosis[J].J Hum Genet,2002,47(8):400-406.
9Cao J, Venton L, Sakata T, et al. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice[J].J Bone Miner Res,2003,18(2):270-272.
10Choi Y. Regulation of osteoclastogenesis by immuno-regulatory molecules[A].Minneapolis:Paper presented at: 25th Annual Meeting of the American Society for Bone and Mineral Research,September 21, 2003.
二级参考文献34
1Han K O，J Bone Miner Res，1997年，12卷，S617页
2Morrison N A，Nature，1997年，387卷，106页
3Tsai K S，Bone，1996年，19卷，513页
4Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:309-319.
5Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun, 1999, 256:449-455.
6Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem, 1998, 273:14363-14367.
7Sumbrook J. Molecular cloning laboratory manual. 2nd ed. New York: Cold Spring Harbor laboratory Press, 1989. 345-897.
9Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology, 1999, 140:4367-4370.
10Atkins G, Haynes DR, Graves SE, et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res, 2000, 15: 640-649.
